In human breast cancer, bromodomain adjacent to zinc finger domain 2A (BAZ2A) and gamma-aminobutyric acid type A receptor subunit epsilon (GABRE) have been recognized as potential therapeutic targets [12, 13]. Here, GABRE is linked to breast carcinoma.